Protein Engineering Market to grow with a CAGR of 11.00%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global Protein Engineering Market.
According
to TechSci Research report, “Global Protein Engineering Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Protein Engineering
Market has valued at USD 2.56 billion in 2022 and is anticipated to witness an
impressive growth in the forecast period with a CAGR of 11.00% through 2028. This
can be due to collaborations and partnerships among leading companies with a
diverse approach to merge the expertise of individual companies and to
strengthen their position in the market.
Advancements
in genomic research have indeed been a driving force behind the increasing
demand in the global protein engineering market. Genomic research, which
involves the study of an organism's complete set of genes (its genome), has
provided valuable insights into the genetic basis of various diseases and
biological processes. Genomic research has led to the identification of
specific genes and proteins associated with diseases. This knowledge provides a
basis for developing targeted therapies. Protein engineering is crucial in
designing and optimizing these therapeutic proteins. Genomic data allows for
the identification of genetic variations that impact an individual's response
to treatments. Protein engineering enables the customization of therapeutic
proteins to match the genetic and molecular profiles of individual patients,
facilitating personalized medicine. Understanding the functions of genes and
their protein products is a key goal of genomics. Protein engineering techniques
are used to investigate protein functions and interactions, aiding in the
interpretation of genomic data. Genomic research often provides genetic
sequences, but understanding the three-dimensional structures of proteins is
crucial for drug design. Protein engineering helps predict and design protein
structures, improving drug development.
Browse over XX market data Figures and spread through 110 Pages and an
in-depth TOC on "Protein Engineering Market”
Protein
engineering is the process by which a researcher modifies a protein sequence by
inserting, swapping, or deleting nucleotides in the encoding gene to produce a
modified protein that is better suited than an unmodified protein for a
specific application or purpose. Because more designed proteins and amino acids
are being produced around the world, the industry for protein engineering is
expanding quickly and offering several potentials for expansion. The market is
expanding favorably as protein medications are increasingly preferred to
non-protein ones. The prevalence of lifestyle-related and chronic disorders
such high blood pressure, cardiovascular disease, diabetes, and others will
also increase market demand.
In
March 2022, A research partnership between Amgen and Generate Biomedicines was
announced to identify and develop protein therapies for five clinical targets
across a variety of therapeutic domains and delivery systems. A Digital
Biologics Discovery group has been formed because of Amgen's generative biology
strategy to capitalize on the Company's cutting-edge strengths in biology,
automation, and protein engineering. The objective of generative biology at
Amgen is to use this biologics experience and expertise along with cutting-edge
sequence-based drug design technology to develop complicated multispecific
therapies for a range of challenging disorders. By reducing the time needed for
drug discovery and producing potential lead molecules with predictable
manufacturing and clinical behavior, Amgen's biologics drug discovery expertise
can be combined with Generate Biomedicines' Artificial Intelligence (AI)
platform to further facilitate multispecific drug design.
The cost of
development is a significant challenge in the global protein engineering
market. Developing protein-based products, whether they are therapeutic drugs,
industrial enzymes, or agricultural innovations, can be expensive and
resource-intensive.
Protein engineering projects often require extensive
research and development efforts, including molecular biology experiments,
protein expression and purification, and functional characterization. These
activities can incur substantial costs in terms of laboratory equipment,
materials, and personnel.
State-of-the-art laboratory equipment, including mass
spectrometers, X-ray crystallography machines, and high-throughput screening
systems, is necessary for protein engineering research. Maintaining and
upgrading this infrastructure can be costly. Computational
protein design and structural modelling require access to high-performance
computing clusters and specialized software. The cost of computational
resources can be a significant factor.
Global Protein Engineering Market segmentation is
based on Product Type, Technology, End User, Region and Company
Based on Technology, Global Protein Engineering Market
is segmented into Irrational Protein Design and Rational Protein Design. Rational
protein design, also known as structure-based protein design or rational
protein engineering, is a methodical approach to creating or modifying proteins
with specific desired properties based on a deep understanding of the protein's
structure and function. Unlike directed evolution, which relies on random
mutations and selection, rational protein design is a targeted and
knowledge-driven process.
Rational protein design has several
advantages, including precision and efficiency. It allows researchers to make
specific changes to a protein's structure and function without the need for
time-consuming and resource-intensive directed evolution experiments. This
targeted approach is particularly valuable in applications where safety and
predictability are crucial, such as drug development.
Based on Region, North America dominated the Global Protein Engineering Market.
North America, particularly the United States, is home to some of the world's
largest and most innovative biotechnology and pharmaceutical companies. These
companies are actively involved in protein engineering for drug discovery and
development, leading to significant market activity. The region has a
well-established ecosystem for research and development, with numerous academic
institutions, research centers, and biotechnology hubs. This fosters a culture
of innovation and supports protein engineering research. The region has a
highly skilled workforce in molecular biology, genetics, bioinformatics, and
related fields. This expertise is critical for the success of protein
engineering projects. North America boasts state-of-the-art research
infrastructure, including advanced laboratories, high-performance computing
facilities, and access to cutting-edge technologies, which are essential for
protein engineering research.
Asia-pacific region to fastest growth in
the Global Protein Engineering Market. The Asia-Pacific region, particularly
countries like China, India, and South Korea, has been experiencing significant
growth in its biotechnology and pharmaceutical sectors. These countries have
made substantial investments in research and development, leading to increased
interest and activity in protein engineering. The region offers competitive
operating costs compared to Western countries, making it attractive for
companies looking to establish research and manufacturing facilities for
protein-based products. Many governments in the Asia-Pacific region have been
actively supporting the growth of the biotechnology and life sciences sectors
through funding, grants, and favorable regulatory policies. This support
encourages innovation and investment in protein engineering. The region's large
and increasingly affluent population provides a growing market for
biopharmaceuticals and other protein-based products. The demand for advanced
therapies and medicines drives the need for protein engineering research and
development.
Some
of the major companies operating in the Global
Protein Engineering Market include:
- Agilent
Technologies Inc.
- Amgen
Inc.
- Bruker
Corporation
- Bio-Rad
Laboratories Inc.
- Eli
Lilly and Company
- Merck
KGaA
- Novo
Nordisk AS
- PerkinElmer
Inc.
- Thermo
Fisher Scientific Inc.
- Waters
Corporation
- Genscripts
USA, Inc.
- GE
Healthcare
Download Free Sample Report
Customers can also request
10% free customization on this report
“Certain areas, particularly in
North America, are projected to exert significant demand for biopharmaceutical
products. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the Global Protein Engineering Market in the forecast period,"
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
Protein
Engineering Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented by Product Type (Insulin, Monoclonal Antibodies,
Coagulation Factors (Blood Factors + Tissue Plasminogen), Vaccines, Growth
Factors (Hormones + Cytokine), and Other Product Types), Technology (Irrational
Protein Design and Rational Protein Design), End User (Pharmaceutical and
Biotechnology Companies, Academic Institutions, and Contract Research
Organizations (CROs)), and By Region, Competition evaluated
the future growth potential of Global Protein
Engineering Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Protein Engineering Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com